Gary Lyman

43PUBLICATIONS
206CO-AUTHORS
EndodonticsPsychiatry (incl. psychotherapy)Cancer therapy (excl. chemotherapy and radiation therapy)Regenerative medicine (incl. stem cells)Medical molecular engineering of nucleic acids and proteins
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (43)

|Apr 14, 2026
Cost-Effectiveness of Biosimilar Denosumab Versus Bisphosphonates in Postmenopausal Osteoporosis.

Jeanine Flanigan, Sarah Kane, Fatemeh Mirzayeh Fashami

|May 25, 2023
Mitigating long-term and delayed adverse events associated with cancer treatment: implications for survivorship.

Maryam B Lustberg, Nicole M Kuderer, Aakash Desai

|Apr 21, 2023
Biosimilar Use Among 38 ASCO PracticeNET Practices, 2019-2021.

Brian Bourbeau, Gary H Lyman, Xiudong Jennifer Lei

|Apr 19, 2023
Venous Thromboembolism Prophylaxis and Treatment in Patients With Cancer: ASCO Guideline Update.

Nigel S Key, Alok A Khorana, Nicole M Kuderer

|Apr 07, 2023
ASCO Policy Statement on Biosimilar and Interchangeable Products in Oncology.

Gladys Rodriguez, Joan Mancuso, Gary H Lyman

Pageof 8